Ceribell vs Xtant Medical Holdings
Xtant Medical Holdings is the larger business, with $134m of revenue in fiscal 2025 against $89.1m for Ceribell (1.5 times as much). Ceribell grew faster (36.1% against 14.2%). Xtant Medical Holdings kept more of each dollar of sales as profit: a net margin of 3.7% against -60.0%. Ceribell carries less debt relative to equity (12.8% against 55.7%).
| Latest fiscal year | CeribellCBLL, 2025 | Xtant Medical HoldingsXTNT, 2025 |
|---|---|---|
| Revenue | $89.1m | $134m |
| Revenue growth | 36.1% | 14.2% |
| Net income | −$53.4m | $5.0m |
| Operating margin | -65.6% | 5.4% |
| Net margin | -60.0% | 3.7% |
| Return on equity | -30.8% | 10.6% |
| Free cash flow | −$41.6m | $10.2m |
| Cash | $40.5m | $17.1m |
| Total debt | $19.8m | $28.4m |
| Debt to equity | 12.8% | 55.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 327 | 151 |
| Market value | $1.03bn | $39.3m |
| Price vs our value range | — | — |
| Moat score | — | 38 (Weak) |
| Insider trades, 12 months | 0 buys, 100 sales | 0 buys, 0 sales |